AI
Thursday, June 06, 2019 7:43:33 AM
And I should note, I don't think psPD patients are typically thought to live just 10 to 20 months.
Anyway, you seem to be backing off from that now... using words like "perhaps"... you're sounding like I did back then, lol.
mOS of that group of 11 - looks to be about 60 vs. Gunjur (whoever that is) saw 27.4.
Gunjur is one of the papers referenced by NWBO in the AACR abstract for the Info Arm.
I thought you were familiar with it. Indeed, one of their data points is bullish for NWBO (though I believe it is an outlier). It is posted below in the first image for your use (can't find full text link w/o subscription). Be careful though of just reading that one point and ignoring the other two (you know, the whole confirmation bias thing).
The second image goes to my use of the word "perhaps" and your dicing of the Indeterminants. Even in Gunjur, some of his psPD were short lived (within your "10 to 20 months").
Each trial has subtle differences in how they classify (dice) ePD and psPD. (Recall, NWBO required complete resolution at the second scan to be considered psPD and they only found 1 out of 51 who fit that (unique) definition).
This Info Arm data (that formed a large part of Bosch's -L "update") is highly subjective in how you compare/interpret it. Perfect for pumping (and, LOL, ripe for critiquing).
